Nuvation Bio to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]
Nuvation Bio to Present at the Jefferies London Healthcare Conference
Nuvation Bio Inc. (NYSE: NUVB) had its price target raised by analysts at Royal Bank of Canada from $5.00 to $6.00. They now have an "outperform" rating on the stock.
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update